Margaret E. Macy

2.4k citations

57 papers · 1.3k indexed · h-index 19

Impact in

Neurology top 5%
- Neuroblastoma Research and Treatments
Genetics top 5%
- Glioma Diagnosis and Treatment

Papers in

Neurology 30
- Neuroblastoma Research and Treatments 30
Genetics 14
- Glioma Diagnosis and Treatment 12

Co-authors: R Grimaila Ronald K. Blackman Dinah A. Koehler William M Gelbart Lia Gore Nicholas K. Foreman Arthur K. Liu Steven G. DuBois
Journals: Journal of Clinical Oncology (16 papers)Pediatric Blood & Cancer (6 papers)Blood (4 papers)Neuro-Oncology (4 papers)Journal of Pediatric Hematology/Oncology (3 papers)
Partner nations: United States Canada Australia

In The Last Decade

Margaret E. Macy

53 papers receiving 1.3k citations

Peers

Countries citing papers authored by Margaret E. Macy

Since Specialization

Citations

This map shows the geographic impact of Margaret E. Macy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margaret E. Macy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margaret E. Macy more than expected).

Fields of papers citing papers by Margaret E. Macy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margaret E. Macy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margaret E. Macy. The network helps show where Margaret E. Macy may publish in the future.

Co-authors

The 25 scholars most cited alongside Margaret E. Macy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Margaret E. Macy Line = papers co-authored together Margaret E. Macy links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Open-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing Sarcoma Journal of Clinical Oncology ·Paul A. Meyers, Noah Federman, Najat C. Daw, Peter M. Anderson, Lara E. Davis, AeRang Kim, Margaret E. Macy, 冨雄木下, Ravin Ratan, Richard F. Riedel, Matteo Trucco, James B. Breitmeyer, Jeffrey A. Toretsky, Joseph A. Ludwig	2024	13
2	Palbociclib in Solid Tumor Patients With Genomic Alterations in the cyclinD-cdk4/6-INK4a-Rb Pathway: Results From National Cancer Institute-Children's Oncology Group Pediatric Molecular Analysis for Therapy Choice Trial Arm I (APEC1621I) JCO Precision Oncology ·Margaret E. Macy, Rajen Mody, Joel M. Reid, Jin Piao, Lauren Saguilig, Todd A. Alonzo, Stacey L. Berg, Elizabeth Fox, Brenda J. Weigel, Douglas S. Hawkins, Margaret Mooney, P. Mickey Williams, David R. Patton, Brent Coffey, Sinchita Roy‐Chowdhuri, Naoko Takebe, James V. Tricoli, Katherine A. Janeway, Nita L. Seibel, D. Williams Parsons	2024	2
3	Model‐informed approach to support pediatric dosing for the pan‐PI3K inhibitor copanlisib in children and adolescents with relapsed/refractory solid tumors Clinical and Translational Science ·Peter N. Morcos, Masaru Sanuki, Rolf Burghaus, Jonathan Moss, Adam Lloyd, Barrett H. Childs, Margaret E. Macy, Joel M. Reid, John Chung, Dirk Garmann	2023	3
4	Early‐phase clinical trial eligibility and response evaluation criteria for refractory, relapsed, or progressive neuroblastoma: A consensus statement from the National Cancer Institute Clinical Trials Planning Meeting Cancer ·Julie R. Park, Judith G. Villablanca, Barbara Hero, Brian H. Kushner, Keith Wheatley, Klaus Beiske, Ruth Ladenstein, Sylvain Baruchel, Margaret E. Macy, Lucas Moreno, Nita L. Seibel, Andrew D.J. Pearson, Katherine K. Matthay, Dominique Valteau‐Couanet	2022	7
5	Naxitamab: a humanized anti-glycolipid disialoganglioside(anti-GD2) monoclonal antibody for treatment of neuroblastoma Drugs of today ·Jinho Choi, Firdaus Noor, Lia Gore, Margaret E. Macy	2021	9
6	Experience with ponatinib in paediatric patients with leukaemia British Journal of Haematology ·Jenna Rossoff, Van Huynh, Rachel E. Rau, Margaret E. Macy, Maria Luisa Sulis, Kirk R. Schultz, Michael J. Burke, Uma H. Athale, Maureen M. O’Brien, John Gregory, Inge M. van der Sluis, Frank G. Keller, C. Michel Zwaan, Meinolf Suttorp, Nobuko Hijiya	2020	20
7	1620O Phase I study of TK216, a novel anti-ETS agent for Ewing sarcoma Annals of Oncology ·Joseph A. Ludwig, Noah Federman, Peter M. Anderson, Margaret E. Macy, Lara E. Davis, Richard F. Riedel, Jodi A. Muscal, Najat C. Daw, Ravin Ratan, Jeffrey A. Toretsky, В. Е. Гладышев, Frank J. Hsu, James B. Breitmeyer, Paul A. Meyers	2020	10
8	Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1–2 trial The Lancet Oncology ·Birgit Geoerger, Hyoung Jin Kang, Michal Yalon-Oren, Lynley V. Marshall, Catherine Vézina, Alberto S. Pappo, Theodore W. Laetsch, Antônio Sérgio Petrilli, Martin Ebinger, Jacek Toporski, Julia Glade Bender, Wayne Nicholls, Elizabeth Fox, Steven G. DuBois, Margaret E. Macy, Susan L. Cohn, Kumudu Pathiraja, Scott J. Diede, Scot Ebbinghaus, Navin Pinto	2019	208
9	Bevacizumab in the treatment of radiation injury for children with central nervous system tumors Child s Nervous System ·Dustin Breitenwischer, Arthur K. Liu, Nicholas K. Foreman, بكني الطاهر, Laura Z. Fenton, Margaret E. Macy	2019	10
10	Phase I study of vorinostat in combination with isotretinoin in patients with refractory/recurrent neuroblastoma: A new approaches to Neuroblastoma Therapy (NANT) trial Pediatric Blood & Cancer ·Navin Pinto, Steven G. DuBois, Araz Marachelian, Scott J. Diede, Agne Taraseviciute, Julia Glade Bender, Denice Tsao‐Wei, Susan Groshen, Joel M. Reid, Daphne A. Haas‐Kogan, C. Patrick Reynolds, Min H. Kang, Meredith S. Irwin, Margaret E. Macy, Judith G. Villablanca, Katherine K. Matthay, Julie R. Park	2018	27
11	Entrectinib and other ALK/TRK inhibitors for the treatment of neuroblastoma Drug Design Development and Therapy ·Holly Pacenta, Margaret E. Macy	2018	38
12	Phase 1 study of dalotuzumab monotherapy and ridaforolimus–dalotuzumab combination therapy in paediatric patients with advanced solid tumours European Journal of Cancer ·Didier Frappaz, Sara M. Federico, Andrew D.J. Pearson, Lia Gore, Margaret E. Macy, Steven G. DuBois, Isabelle Aerts, Robert Iannone, Ryan Geschwindt, Arne van Schanke, Rui Wang, Birgit Geoerger	2016	21
13	Non-Rhabdomyosarcoma Soft Tissue Sarcomas in Children: A Surveillance, Epidemiology, and End Results Analysis Validating COG Risk Stratifications International Journal of Radiation OncologyBiologyPhysics ·Timothy V. Waxweiler, Chad G. Rusthoven, Alla Vlasov, Carrye Cost, Nicholas G. Cost, Hao Tang, Timothy Garrington, Brian Greffe, Travis Heare, Margaret E. Macy, Arthur K. Liu	2015	18
14	A phase I trial of arsenic trioxide chemoradiotherapy for infiltrating astrocytomas of childhood Neuro-Oncology ·Kenneth J. Cohen, Iris C. Gibbs, Paul G. Fisher, Robert J. Hayashi, Margaret E. Macy, Lia Gore	2013	38
15	A Multicenter, First-in-Pediatrics, Phase 1, Pharmacokinetic and Pharmacodynamic Study of Ridaforolimus in Patients with Refractory Solid Tumors Clinical Cancer Research ·Lia Gore, Tanya Trippett, Howard M. Katzenstein, Jessica Boklan, Aru Narendran, Amy Smith, Margaret E. Macy, Usama Fareed, Melanie Gerstung von Brandenstein, Rachel M. Squillace, Christopher Turner, Frank G. Haluska, Michael L. Nieder	2013	19
16	Clinical and molecular characteristics of congenital glioblastoma Neuro-Oncology ·Margaret E. Macy, Diane K. Birks, Valerie N. Barton, Michael Chan, Andrew M. Donson, Bette K. Kleinschmidt‐DeMasters, Lynne Bemis, Michael H. Handler, Nicholas K. Foreman	2012	34
17	A multi‐center phase Ib study of oxaliplatin (NSC#266046) in combination with fluorouracil and leucovorin in pediatric patients with advanced solid tumors Pediatric Blood & Cancer ·Margaret E. Macy, Trịnh Thái Vy, James A. Whitlock, Stephen P. Hunger, Jessica Boklan, Aru Narendran, Cynthia E. Herzog, R.J. Arceci, Rochelle Bagatell, Tanya Trippett, Uwe Christians, Usama Fareed, S. Percy Ivy, Lia Gore	2012	8
18	Pharmacokinetically Guided Phase 1 Trial of the IGF-1 Receptor Antagonist RG1507 in Children with Recurrent or Refractory Solid Tumors Clinical Cancer Research ·Alex Singleton, Cynthia E. Herzog, Tanya Trippett, Joseph F. Grippo, Jacqueline Orenstein, Elizabeth Fox, Margaret E. Macy, 练衡, Patricia Whitcomb, Alberta Aikin, Gail S. Wright, Sergey Yurasov, Frank M. Balis, Lia Gore	2010	41
19	Vandetanib mediates anti-leukemia activity by multiple mechanisms and interacts synergistically with DNA damaging agents Investigational New Drugs ·Margaret E. Macy, Deborah DeRyckere, Lia Gore	2010	6
20	Bevacizumab as Therapy for Radiation Necrosis in Four Children With Pontine Gliomas International Journal of Radiation OncologyBiologyPhysics ·Arthur K. Liu, Margaret E. Macy, Nicholas K. Foreman	2009	56

About Margaret E. Macy

Margaret E. Macy is a scholar working on Neurology, Genetics, Hematology, Oncology and Pulmonary and Respiratory Medicine, having authored 57 papers that have together received 1.3k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (30 papers), Glioma Diagnosis and Treatment (12 papers), Cancer therapeutics and mechanisms (9 papers), Sarcoma Diagnosis and Treatment (9 papers), CAR-T cell therapy research (8 papers), Lung Cancer Research Studies (8 papers), Acute Lymphoblastic Leukemia research (7 papers) and Acute Myeloid Leukemia Research (6 papers). The work is most often cited by research in Neurology (329 citations), Genetics (219 citations), Oncology (385 citations), Pathology and Forensic Medicine (192 citations) and Cancer Research (149 citations). Margaret E. Macy has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include R Grimaila, Ronald K. Blackman, Dinah A. Koehler, William M Gelbart, Lia Gore, Nicholas K. Foreman, Arthur K. Liu, Steven G. DuBois, Elizabeth Fox and Elizabeth C. Engle. Their work appears in journals such as Journal of Clinical Oncology, Pediatric Blood & Cancer, Blood, Neuro-Oncology and Journal of Pediatric Hematology/Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact